Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-03-26 | RA Capital Management, L.P.Unternehmen | 8,77M | 54,62M | Kauf | 6,06 - 6,50 | 26,98M | 48,19% |
| 2026-03-26 | RA Capital Management, L.P.Unternehmen | 8,77M | 54,62M | Kauf | 6,06 - 6,50 | 26,98M | 48,19% |
| 2026-03-23 | Shin Nippon Biomedical Laboratories, Ltd.Unternehmen | 3,90M | 0,00 | Derivative Exercise and Retained Stock | - | 9,61M | 68,38% |
| 2026-02-26 | Dr. Christopher FrancisSenior VP of Corporate Development & Head of Emerging Areas | -33,19k | 357,67k | Derivative Exercise and Sale | 3,87 - 15,09 | 4,37k | - |
| 2026-02-09 | Mr. Kyle B. MoranCFO & Principal Accounting Officer | -3,59k | 48,26k | Verkauf | 13,45 | 57,26k | -5,90% |
| 2026-02-09 | Dr. Paul B. BolnoPresident, CEO & Director | -10,48k | 140,96k | Verkauf | 13,45 | 19,77k | -34,64% |
| 2026-02-09 | Dr. Christopher FrancisSenior VP of Corporate Development & Head of Emerging Areas | -1,88k | 25,33k | Verkauf | 13,45 | 4,37k | -30,13% |
| 2026-02-09 | Dr. Chandra VargeeseCTO | -3,23k | 43,42k | Verkauf | 13,45 | 334,87k | -0,95% |
| 2026-01-02 | Dr. Christopher FrancisSenior VP of Corporate Development & Head of Emerging Areas | -9,38k | 120,82k | Derivative Exercise and Sale | 3,14 - 16,70 | 25,00k | - |
| 2025-12-11 | GSK Equity Investments, LimitedUnternehmen | 1,47M | 27,93M | Kauf | 19,00 | - | - |
| 2025-12-08 | Dr. Christopher FrancisSenior VP of Corporate Development & Head of Emerging Areas | -441,03k | 4,32M | Derivative Exercise and Sale | 2,83 - 16,00 | 25,00k | - |
| 2025-12-08 | Mr. Adrian George RawcliffeIndependent Director | -42,00k | 379,26k | Derivative Exercise and Sale | 5,97 - 15,00 | 12,70k | - |
| 2025-12-09 | Mr. Kyle B. MoranCFO & Principal Accounting Officer | 36,00k | 294,12k | Derivative Exercise and Retained Stock | 8,17 | 48,37k | 291,14% |
| 2025-12-08 | Mr. Kyle B. MoranCFO & Principal Accounting Officer | -260,00k | 2,86M | Derivative Exercise and Sale | 2,83 - 20,03 | 48,37k | - |
| 2025-12-09 | Mr. Kyle B. MoranCFO & Principal Accounting Officer | -36,00 | 729,00 | Automatic Disposition | 20,25 | 48,37k | -0,07% |
| 2025-12-08 | Ms. Aik Na TanIndependent Director | -119,23k | 1,04M | Derivative Exercise and Sale | 3,50 - 15,00 | 0,00 | - |
| 2025-12-08 | Ms. Aik Na TanIndependent Director | -14,99k | 207,96k | Verkauf | 12,75 - 15,00 | 0,00 | -100,00% |
| 2025-12-08 | Dr. Gregory L. VerdineFounder & Director | -20,00k | 269,46k | Automatic Disposition | 13,09 - 14,05 | 262,52k | -7,08% |
| 2025-12-08 | Dr. Mark H. N. CorriganIndependent Director | -16,12k | 217,30k | Automatic Disposition | 13,09 - 14,07 | 0,00 | -100,00% |
| 2025-12-08 | Mr. Christian O. HenryIndependent Chairperson | -87,00k | 846,36k | Derivative Exercise and Sale | 3,50 - 18,02 | 0,00 | - |
| 2025-12-08 | Mr. Christian O. HenryIndependent Chairperson | -6,45k | 82,17k | Automatic Disposition | 12,75 | 0,00 | -100,00% |
| 2025-12-08 | Ms. Heidi L. WagnerIndependent Director | -14,00k | 105,42k | Derivative Exercise and Sale | 5,97 - 14,00 | 16,12k | - |
| 2025-11-13 | Mr. Adrian George RawcliffeIndependent Director | -16,12k | 109,42k | Automatic Disposition | 6,79 | 0,00 | -100,00% |
| 2025-11-13 | RA Capital Management, L.P.Unternehmen | 1.000,00 | 6,69k | Kauf | 6,69 | 18,20M | 0,01% |
| 2025-11-13 | RA Capital Management, L.P.Unternehmen | 1.000,00 | 6,69k | Kauf | 6,69 | 18,20M | 0,01% |
| 2025-08-22 | Dr. Paul B. BolnoPresident, CEO & Director | -217,35k | 2,19M | Automatic Disposition | 10,10 | 0,00 | -100,00% |
| 2025-08-22 | Dr. Gregory L. VerdineFounder & Director | -10,00k | 100,00k | Automatic Disposition | 10,00 | 272,52k | -3,54% |
| 2025-08-15 | Ms. Aik Na TanIndependent Director | -21,00k | 2,52k | Derivative Exercise and Sale | 9,13 - 9,25 | 14,99k | - |
| 2025-08-13 | Mr. Christian O. HenryIndependent Chairperson | -9,67k | 85,19k | Automatic Disposition | 8,81 | 16,95k | -36,33% |
| 2025-08-05 | Ms. Aik Na TanIndependent Director | -1,13k | 9,86k | Automatic Disposition | 8,75 | 14,99k | -6,99% |
| 2025-08-05 | Mr. Ken TakanashiIndependent Director | -4,87k | 42,63k | Automatic Disposition | 8,75 | 11,24k | -30,23% |
| 2025-06-13 | Dr. Gregory L. VerdineFounder & Director | -30,00k | 208,50k | Automatic Disposition | 6,95 | 266,40k | -10,12% |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
